ABOUT US

In February 2021 @ Copenhagen Denmark Synobody was founded by Emil Arvedsen, PhD, and Jannik Faliu, MSc, in the hopes of minimizing the gap and break down barriers between researchers and nanobody technology. The goal was to develop a Synthetic Nanobody screening platform for identifying new theraputics, diagnostics and analytical tools. 
The Synobody team is driven by a passion for creating a self sustained company with an impact on global research.